Brighton hospitals recruit the 100th patient in the EmERGE Validation Study

Brighton hospitals recruit the 100th patient in the EmERGE Validation Study

Brighton has enrolled their 100th patient in the EmERGE validation study in the month of July 2017. Recruitment started in Zagreb and Brighton in April, and this rapid uptake of the new and innovative mHealth application developed byEmERGE shows that there is a clear demand for simplified and streamlined services for people living with HIV. Shorter clinic visits, easier tracking of clinical results, faster communication with the medical staff are key benefits of using the EmERGE health app on your smartphone. Another additional benefit is that the clinics participating in the project can consolidate, coordinate and compare their cohort data thanks to a standard back-end system that generates similar and comparable datasets. The purpose of the EmERGE validation study is to assess the impact of theEmERGE mHealth platform on patient self-management and empowerment in those living with stable HIV infection. This is being assessed at five clinical sites (Antwerp, Barcelona, Brighton, Lisbon and Zagreb).

#NEWSLETTER #Brightonhospitals #EmERGEValidationStudy

12 views0 comments
Project Members
European AIDS Treatment Group
University of Sussex
University of Brighton
Klinika Za İnfektivne Bolesti "Dr. Fran Mihaljević" - Croatia
Centro Hospitalar De Lisboa Central, Epe - Portugal
Brighton And Sussex University Hospitals NHS Trust - United Kingdom
EmERGE mHEALTH LTD. - Horizontal Transpa
Institute of Tropical Medicine Antwerp
Modus Ltd
Universidad Politecnica De Madrid - Spain
Contact Us

EmERGE Project/European AIDS Treatment Group

Tel: +32 2 626 96 40

Address: Interoffices | Avenue des Arts 56-4c
1000 Brussels, Belgium



The EmERGE Project has received funding from the European Union's Horizon 2020. Research and Innovation Programme under Grant Agreement No:643736